F6937
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane
liquid
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
12171500
NACRES:
NA.47
Produtos recomendados
product name
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane, pH range 8.0-8.4, Aqueous mounting medium
Nível de qualidade
forma
liquid
técnica(s)
immunofluorescence: suitable
faixa de pH
8.0-8.4
aplicação(ões)
diagnostic assay manufacturing
hematology
histology
temperatura de armazenamento
2-8°C
Categorias relacionadas
Descrição geral
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane is an aqueous mounting medium for preserving the fluorescence of tissue and cell smears.
Aplicação
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane prevents rapid photobleaching of FITC, Texas Red®, AMCA, ™ 488, Alexa Fluor 594, Cy® dyes, and tetramethylrhodamine.
Princípio
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane mounting medium is fortified with 1,4-Diazabicyclo[2.2.2]octane (a generic version of DABCO®), an anti-fade reagent used to retard photobleaching of fluorescein and other fluorescent dyes.
Informações legais
ALEXA FLUOR is a trademark of Life Technologies
Cy is a registered trademark of Cytiva
DABCO is a registered trademark of Air Products & Chemicals, Inc.
FluoroShield is a trademark of ImmunoBioScience Corp.
Texas Red is a registered trademark of Life Technologies
produto relacionado
Nº do produto
Descrição
Preços
Palavra indicadora
Danger
Frases de perigo
Declarações de precaução
Classificações de perigo
Eye Dam. 1
Código de classe de armazenamento
12 - Non Combustible Liquids
Classe de risco de água (WGK)
WGK 1
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Os clientes também visualizaram
![1,4-Diazabicyclo[2.2.2]octane for synthesis](/deepweb/assets/sigmaaldrich/product/images/488/587/f5a877b3-e573-4686-931f-648015f4d284/640/f5a877b3-e573-4686-931f-648015f4d284.jpg)
![Bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]octane adduct](/deepweb/assets/sigmaaldrich/product/structures/978/293/6c8c7fbe-4b40-4576-bd40-94ac58cbe057/640/6c8c7fbe-4b40-4576-bd40-94ac58cbe057.png)
![1,4-Diazabicyclo[2.2.2]octane bis(sulfur dioxide) adduct ≥95% (sulfur, elemental analysis)](/deepweb/assets/sigmaaldrich/product/structures/158/739/a9df497b-883d-40f1-ac45-bf699dcee9f9/640/a9df497b-883d-40f1-ac45-bf699dcee9f9.png)
Nour W Al Haj Baddar et al.
Developmental dynamics : an official publication of the American Association of Anatomists, 248(2), 189-196 (2018-12-21)
Among vertebrates, salamanders are unparalleled in their ability to regenerate appendages throughput life. However, little is known about early signals that initiate regeneration in salamanders. Ambystoma mexicanum embryos were administered tail amputations to investigate the timing of reactive oxygen species
Ibtisam A Abbas Al-Darkazly et al.
IEEE journal of translational engineering in health and medicine, 8, 4100113-4100113 (2020-01-31)
Objective: investigation of the extra-low-frequency (ELF) stimulation effect on blood-cell proteins, that causes variation in its electrostatic-state. A hypothesis that this results in the conformational change in the blood-cell proteins which could enhance immune activity is explored. Since HIV-1 and
Morphological changes of cortical and hippocampal neurons after treatment with VEGF and bevacizumab.
Latzer P, et al.
CNS Neuroscience & Therapeutics, 22(6), 440-450 (2016)
Anna Wolters et al.
Neural regeneration research, 16(11), 2243-2249 (2021-04-06)
One of the major challenges in emergency medicine is out-of-hospital cardiac arrest (OHCA). Every year, about 53-62/100 000 people worldwide suffer an out-of-hospital cardiac arrest with serious consequences, whereas persistent brain injury is a major cause of morbidity and mortality
Mariana L Casalia et al.
Annals of neurology, 82(4), 530-542 (2017-08-24)
A significant proportion of the more than 50 million people worldwide currently suffering with epilepsy are resistant to antiepileptic drugs (AEDs). As an alternative to AEDs, novel therapies based on cell transplantation offer an opportunity for long-lasting modification of epileptic
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica